Q: What do you think about the fertility space? Progeny (PGNY) for one but who would be your top 3 picks long term coming out of this sector?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $65.22)
-
State Street Health Care Select Sector SPDR ETF (XLV $142.84)
-
Fidelity MSCI Health Care Index ETF (FHLC $68.94)
Q: good morning, I would like to know if there are a couple of heath care ETFs that pay a dividend as well, that you think will be good buys. thank you.
Q: Can you simplify the news on this stock today for me is it good news should I keep holding this stock Thanks
-
Teladoc Health Inc. (TDOC $5.95)
-
WELL Health Technologies Corp. (WELL $4.21)
-
CloudMD Software & Services Inc. (DOC $0.04)
Q: Do you have a favorite - or2 - in this space? I can tolerant medium risk and would be looking for growth more than income. Thanks
I find the new charts very useful,
I find the new charts very useful,
Q: Am looking at Illumina for a long term hold and as always value your opinion on it's future prospects. I also hold Guardant Health and GUD in health care.
John
John
Q: With the massive disruption to the healthcare space, I'm looking for your opinion on this ETF as a way to play this disruption, and the evolution of healthcare as we know it.
Q: In order to increase my holdings in Healthcare, I bought Theratechnologies 2 years ago at $7.21 when 5i was bullish on the stock. The stock did quite well for awhile and I was very happy. It closed on Friday at $2.68 (not so happy anymore). Is this company expected to recover or should I accept my losses and sell?
Q: May I please have your thoughts on this corporation. It has been slowly climbing and looks interesting
John
John
Q: Hi Group I have held GILD for 2 yrs and its just keeps going down is it time to take the loss ? (down 25%) also owned ABBV for 2 yrs also it to is a loser I know you like it please explain why I should continue to hold or? lastly GUD is a dog that I have been holding since the $10 plus days (they clearly are long gone is this a candidate for tax loss selling? appreciate your help on the above 3 questions
Q: I hold a position in GUD and am considering selling it to harvest a tax loss. Looking at the chart, a downtrend, when would be the ideal time to sell?.....Tom
Q: I've held CRH for a number of years riding it up to $12 and back down again. What are your thoughts on this company, should I sell or hold?
Q: Hello can you please tell me level of debt? Insider ownership?
How does their offering differ from Teladoc? Are they currently limited to US? Google invested $100,000,000 will their be integration with Google and and various entities going forward?
How does their offering differ from Teladoc? Are they currently limited to US? Google invested $100,000,000 will their be integration with Google and and various entities going forward?
Q: What's your take on the Horizons share price in the last week? There was good news about a phase 2 trial but the share price doesn't reflect that.
Thanks.
Thanks.
Q: Thoughts on SZLS? Thanks
Q: Why has trading been halted (Doc) for two day. The new cfo news is out there? Do you still like Doc are they a takeover candidate?
Are ptq and vmd take over candidates?
Are ptq and vmd take over candidates?
Q: DOC was halted all day yesterday. The news of the financing is now out. Why is it still not trading?
Q: What is your opinion of Aptose Biosciences? It seems to be getting noticed by analysts. Thanks very much
-
AbbVie Inc. (ABBV $203.89)
-
Bristol-Myers Squibb Company (BMY $57.59)
-
Medtronic plc. (MDT $79.37)
-
Merck & Company Inc. (MRK $110.95)
-
Pfizer Inc. (PFE $26.26)
Q: Can I get your thoughts on the valuation of the healthcare industry? Could you provide a few picks on dividend paying healthcare stocks?
Thanks,
Joe
Thanks,
Joe
Q: Could you please compare these two.
Which one you prefer today?
Thanks,
Milan
Which one you prefer today?
Thanks,
Milan
Q: Can you please explain what this means & why it is impacting the price? Thanks!
Vaxart (NASDAQ:VXRT) is down 6% premarket on increased volume. Shares have sold off over 20% since last week after it disclosed a $250M at-the-market stock sales deal with Jefferies.
Vaxart (NASDAQ:VXRT) is down 6% premarket on increased volume. Shares have sold off over 20% since last week after it disclosed a $250M at-the-market stock sales deal with Jefferies.